Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (386)	5/13/2002 2:06:03 PM
From: Jibacoa	of 544

PHA seems to have found a temporary bottom at the 39 level.<g> In today's "Power Lunch" at CNBC a reporter from the WSJ was trying to give PHA a boost, talking about their anti-hypertensive drug Eplerenone as a potential 500M to 1 billion "block-buster".<g> Eplerenone is designed to specifically block the effects of aldosterone. The FDA accepted an NDA for Eplerenone for the treatment of hypertension and PHA is planning on filing a supplemental NDA for the treatment of congestive heart failure some time next year. The stocks needs to close above 42.20 to get off from its present down-trend.<g> siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next